Compare Novo Nordisk A/S (NVO) vs Sprott Uranium Miners ETF (URNM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Sprott Uranium Miners ETF — how do they compare? Novo Nordisk A/S trades at $49.35 (market cap $220.53B), while Sprott Uranium Miners ETF trades at $50.32. The key difference: Novo Nordisk A/S pays a 3.63% dividend while Sprott Uranium Miners ETF pays none, and Novo Nordisk A/S is trading nearer its 52-week high, Sprott Uranium Miners ETF nearer its low. Which is the better fit depends on your goals.
| NVO | URNM | |
|---|---|---|
Market Cap | $220.53B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $71.70 | $83.99 |
52-Week Low | $35.29 | $44.14 |
Enterprise Value | $239.49B | — |
Dividend Yield | 3.63% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Sprott Uranium Miners ETF
URNM is a pure-play ETF that invests in the global uranium industry. It provides exposure to companies involved in the mining, exploration, and production of uranium, as well as physical uranium holdings, with top assets like Cameco, Uranium Energy Corp, and the Sprott Physical Uranium Trust.
Read more on URNM →
